Meibomian Gland Loss and Dysfunction in Mild versus Moderate-Severe Thyroid Eye Disease
- PMID: 40012795
- PMCID: PMC11856117
- DOI: 10.4103/joco.joco_176_23
Meibomian Gland Loss and Dysfunction in Mild versus Moderate-Severe Thyroid Eye Disease
Abstract
Purpose: To compare meibomian gland (MG) loss and MG dysfunction (MGD) in patients with mild versus moderate-severe thyroid eye disease (TED).
Methods: Consecutive patients with TED and no other causes of dry eye disease underwent meibography and meiboscore of each eyelid were graded as 0 (no MG loss), 1 (<33% loss), 2 (33%-66% loss), and 3 (>66% loss), with a total score of 0-6. MG expression score (0-3), eyelid margin signs of MGD, lipid layer thickness (LLT), ocular surface disease index (OSDI), tear secretion, noninvasive tear break-up time (NITBUT), and tear meniscus height (TMH) were also assessed by a masked observer.
Results: Included were 21 eyes (21 patients) with mild and 19 eyes (19 patients) with moderate-severe TED. The two groups were not different except for a higher frequency of smoking (P < 0.01). Eyes with moderate-severe TED showed a higher upper eyelid meiboscore (P = 0.03), MG expression score (P < 0.01), and tear film osmolality (P = 0.02) as well as lower LLT (P = 0.03). Total meiboscore had a significantly positive correlation with OSDI (rs = 0.37) and tear film osmolality (rs = 0.50) as well as a negative correlation with NITBUT (rs = -0.55), TMH (rs = -0.44), and LLT (rs = -0.38). While older age, male gender, smoking, and longer duration of disease were significantly associated with the higher (≥3) meiboscore in univariate analysis, none remained significant in multivariate analysis.
Conclusion: MG loss and MGD were significantly more severe in moderate-severe than mild TED.
Keywords: Meibography; Meibomian gland dysfunction; Meiboscore; Smoking; Thyroid eye diseases.
Copyright: © 2025 Journal of Current Ophthalmology.
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Kashkouli MB, Alemzadeh SA, Aghaei H, Pakdel F, Abdolalizadeh P, Ghazizadeh M, et al. Subjective versus objective dry eye disease in patients with moderate-severe thyroid eye disease. Ocul Surf. 2018;16:458–62. - PubMed
-
- Ismailova DS, Fedorov AA, Grusha YO. Ocular surface changes in thyroid eye disease. Orbit. 2013;32:87–90. - PubMed
-
- Eckstein AK, Finkenrath A, Heiligenhaus A, Renzing-Köhler K, Esser J, Krüger C, et al. Dry eye syndrome in thyroid-associated ophthalmopathy: Lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. Acta Ophthalmol Scand. 2004;82:291–7. - PubMed
LinkOut - more resources
Full Text Sources